Secured over £2 million of funding for several high-tech projects to accelerate the company’s growth in healthcare markets and address specific health issues in several areas

Contaminated water, to protect against contaminated drinking water and water used in food processing (AQUAVALENS)
Milk, to improve the quality and safety of milk with a key target being the prevention of a potent carcinogen, Aflatoxin M1 and its precursor Aflatoxin B1, from entering the dairy and dairy products (SYMPHONY)
Diseased blood, to provide a novel diagnostic tool and a better understanding of the underlying pathophysiology of rare anaemia (CoMMiTMenT – Combined Molecular Microscopy for Therapy and Personalised Medication in Rare Anaemia Treatments)